Mackay Shields LLC has filed its 13F form on April 28, 2025 for Q1 2025 where it was disclosed a total value porftolio of $514 Million distributed in 361 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Nuveen Amt Free Quality Municipal Income Fund with a value of $44.8M, Ishares Gold Trust with a value of $38.9M, Nuveen Municipal Credit Income Fund with a value of $36.4M, Black Rock Municipal 2030 Target Term Trust with a value of $33.2M, and Talos Energy Inc. with a value of $30.4M.
Examining the 13F form we can see an increase of $14.8M in the current position value, from $499M to 514M .
Below you can find more details about Mackay Shields LLC portfolio as well as his latest detailed transactions.
Portfolio value
$514 Million
Financial Services: $388 Million
Energy: $58.6 Million
ETFs: $43.3 Million
Healthcare: $15.7 Million
Communication Services: $7.18 Million
Consumer Defensive: $404,000
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.59%
-
$0
0.0% of portfolio
-
Q1 2025
Added 7.41%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.28%
-
$0
0.0% of portfolio
-
Q1 2025
Added 16.41%
-
$0
0.0% of portfolio
-
Q1 2025
Added 13.68%
Amphastar Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 42.78%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.65%
Ares Management Corporation
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.52%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 33.34%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.04%
-
$0
0.0% of portfolio
-
Q4 2024
Added 1.14%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 99.28%
Biomarin Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 11.03%
American Airlines Group Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 48.52%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.84%
-
$0
0.0% of portfolio
-
Q2 2024
New
Envista Holdings Corporation
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 49.62%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 0.01%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.74%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.08%
Live Nation Entertainment In
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 3.68%
-
$0
0.0% of portfolio
-
Q1 2025
Added 1.48%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 4.65%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 45.65%
Microchip Technology Inc.
-
$0
0.0% of portfolio
-
Q1 2025
New
Mirum Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.34%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Added 3.19%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 0.44%
-
$0
0.0% of portfolio
-
Q1 2025
Added 2.74%
-
$0
0.0% of portfolio
-
Q4 2024
Added 5.95%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 17.89%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.23%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 1.16%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.62%
Hewlett Packard Enterprise C
-
$0
0.0% of portfolio
-
Q1 2025
Added 97.81%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.35%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 89.87%
-
$0
0.0% of portfolio
-
Q2 2024
New